The Food and Drug Administration is advising consumers not to purchase or use Rhino 11 Gummy, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores.
Similar Posts
National Drug Code Database Background Information
National Drug Code Database Background InformationAccolade Pacemaker Devices by Boston Scientific and Potential Need for Early Device Replacement – FDA Safety Communication
Read the FDA’s recommendations related to Accolade pacemaker devices by Boston Scientific and a potential need for early device replacement.Office of New Drugs Custom Medical Queries (OCMQs)
Office of New Drugs Custom Medical Queries (OCMQs) are standardized groupings of similar adverse event terms intended to assist with the identification of potential safety issues during review of adverse event data.Acetaminophen
Acetaminophen: FDA encourages the safe use of over-the-counter (OTC) and prescription (Rx) pain medicines. The FDA has taken action to improve the safety of consumers when using acetaminophen. Information for use during pregnancy, in children, and risk of rare skin disease is provided to help consumCommissioner’s National Priority Voucher (CNPV) Pilot Program
FDA Commissioner’s National Priority Voucher Program. The Commissioner’s National Priority Voucher Program offers an unprecedented opportunity to reduce drug and biologic review times from 10-12 months to just 1-2 months.